Skip to main content
Eleni Tiniakou, MD, Rheumatology, Houston, TX

Eleni Tiniakou MD


Rheumatology Fellow

Join to view full profile
  • 6410 Fannin StSte 450Houston, TX 77030

  • Phone+1 713-500-6900

Dr. Tiniakou is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Rheumatology, 2013 - 2015
  • Bridgeport Hospital/Yale University
    Bridgeport Hospital/Yale UniversityResidency, Internal Medicine, 2009 - 2012
  • University of Athens
    University of AthensClass of 2006

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2020 - Present
  • TX State Medical License
    TX State Medical License 2025 - 2027
  • MD State Medical License
    MD State Medical License 2016 - 2025
  • NC State Medical License
    NC State Medical License 2021 - 2022
  • MA State Medical License
    MA State Medical License Active through 2013
  • Rheumatology
    American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
  • CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017

Publications & Presentations

PubMed

Press Mentions

  • Management of Challenging Cases in Myositis
    Management of Challenging Cases in MyositisOctober 31st, 2025

Grant Support

  • The MIGHT Trial - An Exploratory Clinical Trial of IVIG in anti-HMGCR ImmuneMediated Necrotizing MyopathyUNIVERSITY OF ALABAMA AT BIRMINGHAM2024–2027
  • RNA: Polymerase III specific CD8+ T cells: a mechanistic insight into cancer-induced autoimmunity in sclerodermaUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON2025–2026
  • Delineating the interplay between nucleic-acid-dependent phase separation and immune responses against cGAS in SLEJOHNS HOPKINS UNIVERSITY2024–2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: